| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/09/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 22.3k | $37.00 | $825k | | 08/09/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 45.5k | $45.66 | $2.1M | | 01/20/2023 |
| 01/20/2023 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 36.4k | $0.00 | $0 | | 01/20/2023 |
| 01/17/2023 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 619 | $42.38 | $26.2k | | 01/17/2023 |
| 01/17/2023 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 947 | $42.38 | $40.1k | | 01/17/2023 |
| 01/09/2023 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2.1k | $45.37 | $94.7k | | 01/09/2023 |
| 12/21/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 3.2k | $40.41 | $131.3k | | 12/19/2022 |
| 12/19/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 19.1k | $0.00 | $0 | | 12/19/2022 |
| 06/08/2022 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 24k | $2.01 | $48.2k | | 06/08/2022 |
| 01/18/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 627 | $120.48 | $75.5k | | 01/14/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 10.8k | $0.00 | $0 | | 01/14/2022 |
| 01/14/2022 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 17.8k | $124.31 | $2.2M | | 01/14/2022 |
| 01/07/2022 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2k | $135.94 | $267k | | 01/07/2022 |
| 01/03/2022 | Surface Oncology, Inc. | SURF | Grant | Stock Option (Right to Buy) | 24k | $5.08 | $121.9k | | 01/03/2022 |
| 03/19/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 1.4k | $176.42 | $238.2k | | 03/19/2021 |
| 03/19/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 431 | $177.71 | $76.6k | | 03/19/2021 |
| 03/19/2021 | Mirati Therapeutics, Inc. | MRTX | Exercise | Non Qualified Stock Option (right to buy) | 2.4k | $114.33 | $270.8k | | 03/19/2021 |
| 03/19/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 588 | $175.54 | $103.2k | | 03/19/2021 |
| 01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 7k | $0.00 | $0 | | 01/15/2021 |
| 01/15/2021 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 11k | $214.47 | $2.4M | | 01/15/2021 |
| 01/07/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 2.1k | $216.33 | $447.6k | | 01/07/2021 |
| 01/07/2021 | Mirati Therapeutics, Inc. | MRTX | Sale | Common Stock | 9 | $215.31 | $1.9k | | 01/07/2021 |
| 01/06/2020 | Mirati Therapeutics, Inc. | MRTX | Grant | Employee Stock Option (Right to Buy) | 32.5k | $114.33 | $3.7M | | 01/06/2020 |
| 01/06/2020 | Mirati Therapeutics, Inc. | MRTX | Grant | Common Stock | 21.9k | $0.00 | $0 | | 01/06/2020 |
| 10/01/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Exercise | Restricted Stock Units | 20.2k | $0.00 | $0 | | 10/01/2019 |
| 10/01/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Payment of Exercise | Common Stock | 7k | $15.46 | $108.1k | | 10/01/2019 |
| 02/12/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Options to purchase common stock | 71.6k | $16.65 | $1.2M | | 02/12/2019 |
| 02/12/2019 | HALOZYME THERAPEUTICS, INC. | HALO | Grant | Restricted Stock Units | 37.5k | $0.00 | $0 | | 02/12/2019 |